-
1
المؤلفون: María José Méndez-Vidal, Enrique Gonzalez-Billalabeitia, Nuria Lainez, Urbano Anido, Álvaro Montesa, Miguel Angel Climent, J. P. Maroto, Javier Puente, Ángel Francisco Zazo Rodríguez, Curro Zambrana, Julio Lambea, A. González-del-Alba
المساهمون: [Gonzalez-del-Alba, Aranzazu] Hosp Univ Puerta Hierro Majadahonda, Med Ongol Dept, Calle Joaquin Rodrigo 2, Madrid 28222, Spain, [Puente, Javier] Hosp Clin San Carlos, CIBERONC, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Med Oncol Dept, Madrid, Spain, [Anido, Urbano] Complejo Hosp Univ Santiago, Oncol Dept, Santiago De Compostela, Spain, [Angel Climent, Miguel] IVO, Med Oncol Dept, Valencia, Spain, [Gonzalez-Billalabeitia, Enrique] Univ Murcia, IMIB, Hosp Univ Morales Meseguer, Hematol & Med Oncol Dept, Murcia, Spain, [Gonzalez-Billalabeitia, Enrique] Univ Catolica San Antonio Murcia UCAM, Murcia, Spain, [Lainez, Nuria] Complejo Hosp Navarra, Med Oncol Dept, Pamplona, Spain, [Lambea, Julio] Hosp Clin Univ Lozano Blesa, Med Oncol Dept, Zaragoza, Spain, [Pablo Maroto, Jose] Hosp Santa Creu & Sant Pau, Med Oncol Dept, Barcelona, Spain, [Jose Mendez-Vidal, Maria] Hosp Univ Reina Sofia, Med Oncol Dept, Cordoba, Spain, [Montesa, Alvaro] Hosp Reg Malaga, Med Oncol Dept, Malaga, Spain, [Rodriguez, Angel] Hosp Leon, Med Oncol Dept, Leon, Spain, [Zambrana, Curro] Hosp Univ Infanta Sofia, Med Oncol Dept, San Sebastian De Reyes, Spain, Sanofi
المصدر: Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Therapeutic Advances in Medical Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pauمصطلحات موضوعية: Oncology, Radium-223, medicine.medical_specialty, radium-223, medicine.medical_treatment, Docetaxel, Androgen deprivation therapy, Castration resistant, chemotherapy, lcsh:RC254-282, 1st-line, Upfront, Increased survival, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Internal medicine, medicine, Enzalutamide, 030212 general & internal medicine, Chemotherapy, Cabazitaxel, enzalutamide, business.industry, Abiraterone acetate, Men, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, metastatic castration-resistant prostate cancer, chemistry, 030220 oncology & carcinogenesis, androgen-deprivation therapy, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c0c26be19d7be0e8eed0ba68bd453c9Test
https://doaj.org/article/75ff313d187749adb79d84a4a14b63f7Test -
2
المؤلفون: Antonio Fernández, Jose Luis Aguilar, Pablo Cerezuela, A. Saenz, S. Ros, Alberto Carmona-Bayonas, Sara Fernández, Claudia Valverde, Daniel Castellano, Mireia Margeli, David Hervás, Xavier Garcia del Muro, Grupo Germinal, Francisco Ayala de la Peña, Josep Guma, Javier Sastre, Ignacio Duran, Begoña Mellado, Samuel Rivera, Nora Sobrevilla, Alfonso Sanchez-Muñoz, Jose R. Germa-Lluch, Enrique Gonzalez-Billalabeitia, Ray Manneh, Maria Isabel Luengo, Pablo Maroto, Jorge Aparicio
المساهمون: [Gonzalez-Billalabeitia, Enrique] Hosp Univ Morales Meseguer IMIB, Murcia, Spain, [Luengo, Maria I.] Hosp Univ Morales Meseguer IMIB, Murcia, Spain, [Gonzalez-Billalabeitia, Enrique] Univ Catolica San Antonio Murcia UCAM, Murcia, Spain, [Castellano, Daniel] Hosp Univ 12 Octubre, Madrid, Spain, [Manneh, Ray] Hosp Univ 12 Octubre, Madrid, Spain, [Sobrevilla, Nora] Inst Nacl Cancerol, Mexico City, DF, Mexico, [Guma, Josep] URV, Hosp San Joan de Reus, IISSPV, Tarragona, Spain, [Hervas, David] Inst Invest Sanitaria La Fe, Valencia, Spain, [Aparicio, Jorge] Hosp Univ La Fe, Valencia, Spain, [Sanchez-Munoz, Alfonso] Hos Univ Reg & Virgen de la Victoria Malaga, Invest Clin & Traslac Canc, Inst Invest Biomed Malaga IBIMA, Malaga, Spain, [Mellado, Begona] Hosp Clin Barcelona, IDIBAPS, Serv Oncol Med, Barcelona, Spain, [Saenz, Alberto] Hosp Clin Lozano Blesa, Zaragoza, Spain, [Valverde, Claudia] Hosp Univ Vall dHebron, Barcelona, Spain, [Fernandez, Antonio] Complejo Hosp Univ Albacete, Albacete, Spain, [Margeli, Mireia] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Badalona, Spain, [Duran, Ignacio] Hosp Univ Virgen del Rocio, Seville, Spain, [Fernandez, Sara] Hosp Cent Asturias, Oviedo, Spain, [Sastre, Javier] Hosp Clin San Carlos, Madrid, Spain, [Ros, Silverio] Hosp Virgen Arrixaca, Murcia, Spain, [Maroto, Pablo] Hosp Santa Creu & Sant Pau, Barcelona, Spain, [Cerezuela, Pablo] Hosp Santa Lucia, Cartagena, Spain
المصدر: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instnameمصطلحات موضوعية: Risk, 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Pathology, Prognostic variable, Survival, Adolescent, medicine.medical_treatment, Disease-Free Survival, 03 medical and health sciences, Bleomycin, Young Adult, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Registries, Young adult, Child, Survival rate, Tumors, Aged, Etoposide, Proportional Hazards Models, Chemotherapy, business.industry, Proportional hazards model, Hazard ratio, Venous Thromboembolism, Middle Aged, Neoplasms, Germ Cell and Embryonal, Prognosis, Confidence interval, Cisplatin-based chemotherapy, Survival Rate, 030104 developmental biology, 030220 oncology & carcinogenesis, Cohort, Female, Cisplatin, business, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdaf539679430e46f25ee5ae30f54be3Test
https://hdl.handle.net/10668/10808Test